Medicine
Thiola EC 100 mg delayed-release tablet
Thiola EC 100 mg delayed-release tablet is a prescription medicine containing Tiopronin for oral use, marketed by Mission Pharmacal, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15-30°C (59-86°F).
Key facts
- Active ingredient (INN)
- Tiopronin
- Brand
- Thiola EC
- Strength
- 100 mg
- Dosage form
- Delayed-release tablet
- Route
- Oral
- Packs
- 300 tablets
- Marketing authorisation holder
- Mission Pharmacal
- Manufacturer
- Mission Pharmacal
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15-30°C (59-86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G04BX16 Tiopronin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 June 2019
- Identifiers
- RxCUI 2178075, 2178077, 2178079 +1DailyMed set ID 20298a52-a194-a161-8632-d84b6f26e23cNDC 0178-0902Application NDA211843
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 300 tablet, delayed release in 1 bottle | 0178-0902-01 | Mission Pharmacal | 28 June 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 11 August 1988 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Tiopronin 100 mg delayed-release tablet.
Other strengths and forms of Tiopronin
Clinical summary
Tiopronin is a reducing and complexing thiol indicated , in combination with high fluid intake, alkali, and diet modification, for the prevention of cystine stone formation in adults, among other approved uses. MedsAcross supplies Tiopronin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TioproninFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Thiola prescribing information (Mission Pharmacal) · U.S. National Library of Medicine, DailyMed
Need Thiola EC 100 mg delayed-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.